Real-world effectiveness of second-line Afatinib versus chemotherapy for the treatment of advanced lung squamous cell carcinoma in immunotherapy-naïve patients

Chen Y.-Y.Chang S.-C.Chang C.-Y.Chang C.-F.Lai Y.-C.Wei Y.-F.CHUNG-YU CHEN2022-05-032022-05-0320211471-2407https://www.scopus.com/inward/record.uri?eid=2-s2.0-85119068887&doi=10.1186%2fs12885-021-08920-3&partnerID=40&md5=832d9006271a8bdb84557a8c3a675830https://scholars.lib.ntu.edu.tw/handle/123456789/609270Real-world effectiveness of second-line Afatinib versus chemotherapy for the treatment of advanced lung squamous cell carcinoma in immunotherapy-naïve patientsjournal article10.1186/s12885-021-08920-3347819192-s2.0-85119068887